This notion is supported by a meta-analysis of 13 case-control studies, including more than 11 000 subjects, which showed that the PLCE1 rs2274223 polymorphism was statistically significant associated with an increasing risk of ESCC and GC20. This evidence concerns the gene EIF1B and esophageal squamous cell carcinoma.